On the existence of cardiomesenchymal stem cells

José R Navarro-Betancourt1, Salomón Hernández1

  • 1Molecular Biology Department, School of Medicine, Universidad Panamericana, Mexico.

Medical Hypotheses
|March 15, 2015
PubMed

Insights

Myocardium-resident cardiac stem cells are ideal for cardiac regeneration but limited in supply. Researchers hypothesize that a novel cardiomesenchymal stem cell (CMSC) population could offer a solution for cardiac repair.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Myocardium-resident cardiac stem cells are the most effective for cardiac regeneration but are scarce for therapeutic use.
  • Mesenchymal stem cells exhibit broad differentiation potential but lack specificity for cardiac lineage, limiting their efficiency in cardiac regeneration therapies.
  • The heterogeneity of mesenchymal stem cells suggests the possibility of identifying subpopulations with inherent cardiac differentiation capacity.

Purpose of the Study:

  • To investigate the potential of a specific stem cell subpopulation for cardiac regeneration.
  • To identify a stem cell population combining cardiac and mesenchymal stem cell characteristics for enhanced therapeutic value.

Main Methods:

  • Evaluating surface marker expression to identify stem cell subpopulations with cardiac differentiation potential.
  • Hypothesizing the existence and characteristics of a novel cardiomesenchymal stem cell (CMSC) population.

Main Results:

  • Cardiac stem cells are the most efficient for cardiac regeneration.
  • Mesenchymal stem cells have limited efficiency for cardiac regeneration due to differentiation challenges.
  • A potential exists to identify specific mesenchymal stem cell subpopulations with cardiac differentiation capacity based on surface markers.

Conclusions:

  • Cardiomesenchymal stem cells (CMSCs), possessing both cardiac and mesenchymal stem cell markers, are hypothesized to be ideal candidates for cardiac regeneration therapy.
  • Identifying and isolating CMSCs could overcome the limitations of current stem cell therapies for cardiac repair.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.1K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K